These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32508354)

  • 41. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Zell JA; Ziogas A; Bernstein L; Clarke CA; Deapen D; Largent JA; Neuhausen SL; Stram DO; Ursin G; Anton-Culver H
    Cancer; 2009 Dec; 115(24):5662-71. PubMed ID: 19827153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
    Flossmann E; Rothwell PM;
    Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
    Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
    Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: a meta-analysis.
    Kanik EA; Canbaz H; Colak T; Aydin S
    Curr Ther Res Clin Exp; 2004 Jul; 65(4):345-52. PubMed ID: 24672089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drugs for acute low back pain.
    van der Gaag WH; Roelofs PD; Enthoven WT; van Tulder MW; Koes BW
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013581. PubMed ID: 32297973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
    Grabosch SM; Shariff OM; Wulff JL; Helm CW
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD004121. PubMed ID: 24715225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety.
    Stefansdottir G; De Bruin ML; Knol MJ; Grobbee DE; Leufkens HG
    Drug Saf; 2011 Sep; 34(9):783-92. PubMed ID: 21830840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Buchbinder R; Schlesinger N; van der Heijde D; Landewé RB
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010120. PubMed ID: 25225849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
    Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force.
    Chubak J; Whitlock EP; Williams SB; Kamineni A; Burda BU; Buist DS; Anderson ML
    Ann Intern Med; 2016 Jun; 164(12):814-25. PubMed ID: 27064482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rofecoxib for rheumatoid arthritis.
    Garner SE; Fidan DD; Frankish RR; Judd MG; Towheed TE; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD003685. PubMed ID: 15674912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.
    Wuytack F; Smith V; Cleary BJ
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011352. PubMed ID: 33427305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
    McGettigan P; Henry D
    JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.